Sponsored by:

Molecular Imaging: Page 308

GE installs 1st MBI system in U.S.
By AuntMinnie.com staff writers
GE Healthcare has installed its Discovery NM 750b molecular breast imaging (MBI) system at Capital Health Medical Center - Hopewell in Pennington, NJ.
January 29, 2012
JACC: Questions remain about cardiac radiation's link to cancer
By Eric Barnes
There are still no strong data linking the use of ionizing radiation in cardiac imaging to the development of cancer, though several studies have found that higher radiation exposure may increase the risk of developing cancer, concludes a paper published online January 30 in the Journal of the American College of Cardiology.
January 29, 2012
Manhattan Isotope gets strontium-82 license
By AuntMinnie.com staff writers
Manhattan Isotope Technology has received approval of its radioactive materials license amendment from the radiation control program at the Texas Department of State Health Services.
January 29, 2012
PET/CT detects head/neck cancer recurrences earlier
By Cynthia E. Keen
Routine use of follow-up PET/CT scans can detect local cancer recurrences before they become clinically apparent, and may improve outcomes of subsequent salvage therapy, according to a study presented on Friday at the Multidisciplinary Head and Neck Cancer Symposium in Phoenix.
January 27, 2012
Shine Medical picks Mo-99 plant site in Wis.
By AuntMinnie.com staff writers
Medical isotope firm Shine Medical Technologies has unveiled plans to build a new molybdenum-99 (Mo-99) manufacturing plant in Janesville, WI.
January 24, 2012
Cell>Point inks Brazilian license deal
By AuntMinnie.com staff writers
Radiopharmaceutical developer Cell>Point has signed a long-term collaboration agreement including product licenses for Brazil with MJM Produtos Farmacêuticos e de Radioproteção (Radiopharmacus).
January 24, 2012
BSGI equals MRI as an adjunct in breast cancer cases
By Wayne Forrest
Researchers in Oregon have concluded that breast-specific gamma imaging (BSGI) is equivalent to MRI as an adjunct imaging modality for diagnosing breast cancer. BSGI may be particularly useful in evaluating women at high risk for cancer, or those with dense breasts.
January 24, 2012
2012 01 24 14 20 29 621 Ll Brs Tu3 B Bsgi 2 Thumb
Sofie to receive patent for PET probes
By AuntMinnie.com staff writers
Molecular imaging developer Sofie Biosciences has been told that it will receive a U.S. patent that covers a line of novel PET probes, known as F-18 FAC.
January 23, 2012
NRG gets OK for new nuclear reactor
By AuntMinnie.com staff writers
Radiopharmaceutical producer Nuclear Research and Consultancy Group (NRG) received approval from the Dutch government on January 20 to proceed with a new nuclear research reactor to replace an existing reactor in Petten.
January 22, 2012
ASCO: PET, PET/CT show broad utility in gastrointestinal cancer
By Eric Barnes
SAN FRANCISCO - FDG-PET and PET/CT are critical imaging modalities in diagnosing and managing patients with gastrointestinal cancer, as demonstrated in several lines of research presented at this week's American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium.
January 19, 2012
Almeida named Covidien chairman
By AuntMinnie.com staff writers
Healthcare technology firm Covidien's board of directors has added chairman to President and CEO José Almeida's responsibilities, effective March 13.
January 19, 2012
Navidea touts Alzheimer's study results
By AuntMinnie.com staff writers
Radiopharmaceutical developer Navidea Biopharmaceuticals is touting clinical results from a study that included the use of its late-stage radiopharmaceutical imaging candidate, AZD4694, for detecting cerebral amyloid in Alzheimer's disease patients.
January 19, 2012
Previous Page
Page 308 of 612
Next Page